Navigation Links
Wake Up Call: U.N Takes Stock to Curb Fake Medicines Racket

The Counterfeit Medicines Racket is growing at alarming proportions. The United Nations has risen to the occasion, driving a // world wide initiative , by way of a task force team that would strive to put an end to the sale of counterfeit drugs. A three day meeting is underway in Rome, starting today, February 16th, where all the key players - Pharamaceutical companies, Regulatory bodies and groups which represent the consumers will bring to the table, out- of- the- box solutions, to end this menace of fake drugs.

The stark reality of Fake drugs, a silent killer , has its tentacles spreading world-wide and expected to sky rocket to the tune of $75 billion by 2010, making up almost 10% of the worldwide medicine trade according to the WHO, statistics. This will be a fatal blow to the sick, unwitting targets of a nefarious network.

Howard Zucker, assistant director general for Health Technology and Pharmaceuticals at the WHO, drove the grim reality home , when he said People don't die from carrying a fake handbag or wearing a fake T-shirt. They can die from taking a counterfeit medicine. International police action against the factories and distribution networks should be as uncompromising as that applied to the pursuit of narcotic smuggling.

The WHO’s task force mandate will encompass legislation, law enforcement activities, trade, risk communications and innovative technology solutions. Additionally, WHO plans to extend the reach of the Rapid Alert System Communication Newtwork. Founded in 2005, The RAS , uses the web to follow the distribution activities of drug traders, and this information will be disseminated amonsgt the bearers of authority. The RAS will be spruced up to make such information available internationally, amongst all the stake holders.


'"/>




Page: 1

Related medicine news :

1. Wake-up Call: Two-thirds of Briton Spend Many Sleeping Moments Awake!
2. World Health Organisation Takes a Historic Decision and Approves Treaty to Discourage Smoking
3. World Health Organisation Takes a Historic Decision and Approves Treaty to Discourage Smoking
4. World Health Organisation Takes a Historic Decision and Approves Treaty to Discourage Smoking
5. Bhitarkanika Sanctuary In Orissa Takes Precaution To Monitor Bird Flu
6. Government Takes Tough Stand Against Falling Sex Ratio
7. Bill Gates Takes Personal Interest in AIDS Program
8. 37 times unlucky – Failure to Diagnose Cancer, Takes the Life of a 31 year old fathe
9. So (y) Good: Soy Meal Takes-Off After Bird-Flu Crisis
10. Government Takes Steps to Reduce Binge Drinking Among Britons
11. Its High Time the Australian Government Takes Steps against Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/21/2017)... ... April 21, 2017 , ... Brady (NYSE:BRC), a ... B-595 and B-7569 vinyl label materials received certification for the ... are tested to remain intact and legible, for use on chemical drums shipped by ...
(Date:4/21/2017)... ... ... The Patient Advocacy Community of The Beryl Institute presented Eve DeVaro, Director, Patient ... Award in recognition of her extraordinary contributions to the field of patient advocacy ... Institute’s annual Patient Experience Conference on March 20 in Denver, Colorado. ...
(Date:4/21/2017)... , ... April 21, 2017 , ... ... weeklong campaign, AWARE: A Week of Addiction and Recovery Education, from April 24 ... treating and preventing substance use disorders. , The mission of AWARE is ...
(Date:4/21/2017)... ... April 21, 2017 , ... Metrasens is honoured ... Trade, the UK’s most prestigious award for business success. The company has ... revenues and has grown by a total of 400% over the last six ...
(Date:4/21/2017)... ... April 21, 2017 , ... Westside Dental Associates ... dental care since 1985. After thirty-two years, Dr. Latner has become one of the ... my numerous clients over the years with all their dental needs,” said Dr. Latner, ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 2017  AbbVie (NYSE: ABBV), a global biopharmaceutical ... chronic hepatitis C virus (HCV) infected patients with ... compensated cirrhosis (Child-Pugh A) achieved sustained virologic response ... its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These ... 12 weeks of G/P treatment without ribavirin. Patients ...
(Date:4/20/2017)... 2017 Research and Markets has announced ... Services Market Analysis By Service (Manufacturing, Research), By Country, (Brazil, ... 2025" report to their offering. ... The Latin American pharmaceutical contract manufacturing services ... Low drug registration cost in Latin American countries ...
(Date:4/19/2017)... Calif. , April 19, 2017  IRIDEX Corporation ... will release financial results for the first quarter 2017 ... 2017.  The Company,s management team will host a corresponding ... p.m. ET. Investors interested in listening to ... 707-0665 for domestic callers or (703) 326-3030 for international ...
Breaking Medicine Technology: